These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 10424325)

  • 1. Lack of a pharmacokinetic interaction between atovaquone and proguanil.
    Gillotin C; Mamet JP; Veronese L
    Eur J Clin Pharmacol; 1999 Jun; 55(4):311-5. PubMed ID: 10424325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacokinetics and pharmacodynamics of atovaquone and proguanil for the treatment of uncomplicated falciparum malaria in third-trimester pregnant women.
    Na-Bangchang K; Manyando C; Ruengweerayut R; Kioy D; Mulenga M; Miller GB; Konsil J
    Eur J Clin Pharmacol; 2005 Sep; 61(8):573-82. PubMed ID: 16041597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and pharmacokinetics of atovaquone and proguanil in children with multidrug-resistant Plasmodium falciparum malaria.
    Sabchareon A; Attanath P; Phanuaksook P; Chanthavanich P; Poonpanich Y; Mookmanee D; Chongsuphajaisiddhi T; Sadler BM; Hussein Z; Canfield CJ; Hutchinson DB
    Trans R Soc Trop Med Hyg; 1998; 92(2):201-6. PubMed ID: 9764334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of an interaction between artesunate and atovaquone--proguanil.
    van Vugt M; Edstein MD; Proux S; Lay K; Ooh M; Looareesuwan S; White NJ; Nosten F
    Eur J Clin Pharmacol; 1999 Aug; 55(6):469-74. PubMed ID: 10492061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pharmacokinetics of atovaquone and proguanil in pregnant women with acute falciparum malaria.
    McGready R; Stepniewska K; Edstein MD; Cho T; Gilveray G; Looareesuwan S; White NJ; Nosten F
    Eur J Clin Pharmacol; 2003 Oct; 59(7):545-52. PubMed ID: 12955371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time-dependent pharmacokinetics and drug metabolism of atovaquone plus proguanil (Malarone) when taken as chemoprophylaxis.
    Thapar MM; Ashton M; Lindegårdh N; Bergqvist Y; Nivelius S; Johansson I; Björkman A
    Eur J Clin Pharmacol; 2002 Apr; 58(1):19-27. PubMed ID: 11956669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged protection provided by a single dose of atovaquone-proguanil for the chemoprophylaxis of Plasmodium falciparum malaria in a human challenge model.
    Deye GA; Miller RS; Miller L; Salas CJ; Tosh D; Macareo L; Smith BL; Fracisco S; Clemens EG; Murphy J; Sousa JC; Dumler JS; Magill AJ
    Clin Infect Dis; 2012 Jan; 54(2):232-9. PubMed ID: 22052893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of atovaquone/proguanil compared with mefloquine for treatment of acute Plasmodium falciparum malaria in Thailand.
    Looareesuwan S; Wilairatana P; Chalermarut K; Rattanapong Y; Canfield CJ; Hutchinson DB
    Am J Trop Med Hyg; 1999 Apr; 60(4):526-32. PubMed ID: 10348224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Causal prophylactic efficacy of atovaquone-proguanil (Malarone) in a human challenge model.
    Berman JD; Nielsen R; Chulay JD; Dowler M; Kain KC; Kester KE; Williams J; Whelen AC; Shmuklarsky MJ
    Trans R Soc Trop Med Hyg; 2001; 95(4):429-32. PubMed ID: 11579890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atovaquone and proguanil for Plasmodium falciparum malaria.
    Radloff PD; Philipps J; Nkeyi M; Hutchinson D; Kremsner PG
    Lancet; 1996 Jun; 347(9014):1511-4. PubMed ID: 8684102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atovaquone and proguanil hydrochloride.
    Am J Health Syst Pharm; 2000 Dec; 57(23):2165-6. PubMed ID: 11127694
    [No Abstract]   [Full Text] [Related]  

  • 12. Malarone (atovaquone and proguanil hydrochloride): a review of its clinical development for treatment of malaria. Malarone Clinical Trials Study Group.
    Looareesuwan S; Chulay JD; Canfield CJ; Hutchinson DB
    Am J Trop Med Hyg; 1999 Apr; 60(4):533-41. PubMed ID: 10348225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of atovaquone/proguanil as suppressive prophylaxis for Plasmodium falciparum malaria.
    Shanks GD; Gordon DM; Klotz FW; Aleman GM; Oloo AJ; Sadie D; Scott TR
    Clin Infect Dis; 1998 Sep; 27(3):494-9. PubMed ID: 9770146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacodynamic interactions among atovaquone, proguanil and cycloguanil against Plasmodium falciparum in vitro.
    Thapar MM; Gupta S; Spindler C; Wernsdorfer WH; Björkman A
    Trans R Soc Trop Med Hyg; 2003; 97(3):331-7. PubMed ID: 15228254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Steady-state kinetics of proguanil and its active metabolite, cycloguanil, in man.
    Edstein MD; Veenendaal JR; Scott HV; Rieckmann KH
    Chemotherapy; 1988; 34(5):385-92. PubMed ID: 3180907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atovaquone-proguanil for prophylaxis and treatment of malaria.
    Marra F; Salzman JR; Ensom MH
    Ann Pharmacother; 2003 Sep; 37(9):1266-75. PubMed ID: 12921511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of proguanil in malaria patients treated with proguanil plus atovaquone.
    Edstein MD; Looareesuwan S; Viravan C; Kyle DE
    Southeast Asian J Trop Med Public Health; 1996 Jun; 27(2):216-20. PubMed ID: 9279980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytogenetic and oxidative status of human lymphocytes after exposure to clinically relevant concentrations of antimalarial drugs atovaquone and proguanil hydrochloride in vitro.
    Dinter D; Gajski G; Domijan AM; Garaj-Vrhovac V
    Fundam Clin Pharmacol; 2015 Dec; 29(6):575-85. PubMed ID: 26434663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atovaquone/proguanil: a review of its use for the prophylaxis of Plasmodium falciparum malaria.
    McKeage K; Scott L
    Drugs; 2003; 63(6):597-623. PubMed ID: 12656656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The safety of atovaquone/proguanil in long-term malaria prophylaxis of nonimmune adults.
    Petersen E
    J Travel Med; 2003 May; 10 Suppl 1():S13-5; discussion S21. PubMed ID: 12737755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.